Why It Matters
Global Kratom Coalition (GKC) terminated its lobbying relationship with BGR Government Affairs LLC effective May 1, according to a Lobbying Disclosure Act filing submitted on June 15, 2026.
The GKC lobbying termination marks a shift in how the kratom industry is approaching its federal advocacy strategy. The termination filing, which covered second quarter 2026 activity, reported no compensation for the period following the May 1 end date.
The decision to sever ties with BGR Government Affairs represents a notable change for the kratom industry's Washington presence. BGR Group kratom client relationships have historically been a component of the firm's broader lobbying portfolio, which spans multiple sectors and industries. The termination filing provides limited detail about the financial scale of the relationship before its conclusion, though the zero-dollar reporting for the post-termination period reflects the contract's end.
Broader Context
Kratom (Mitragyna speciosa) is a Southeast Asian tropical plant whose leaves contain alkaloids that interact with opioid receptors, producing stimulant effects at low doses and sedative or pain-relieving effects at higher doses, and is commonly used for pain management, anxiety relief, and easing opioid withdrawal. It remains federally legal but unregulated, and is widely distributed through online retailers, smoke shops, gas stations, and kratom bars.
Kratom lobbying in 2026 has occurred against a backdrop of ongoing federal scrutiny of the botanical substance. The kratom industry has faced regulatory pressure at both the federal and state levels, with various agencies examining the product's safety profile and appropriate classification.
Congressional attention to kratom has fluctuated, with members from different committees expressing varying levels of concern about the substance. The regulatory environment has created incentives for industry groups to maintain an active federal advocacy presence, though the specific legislative developments that prompted the GKC lobbying termination remain unclear from available filings.
The LDA termination filing itself contains no narrative explanation for the decision to end the BGR relationship. Industry observers would need to examine broader regulatory developments and potential shifts in the kratom industry's advocacy priorities to understand the context surrounding this particular representation change.
The Bottom Line
The Global Kratom Coalition BGR separation reflects evolving dynamics in how the kratom industry manages its Washington advocacy. Without information about any subsequent firm hired by Global Kratom Coalition to replace BGR Government Affairs, the full picture of the coalition's current lobbying strategy cannot be determined from available disclosure documents.
The kratom industry lobbying environment continues to develop as federal agencies and Congress engage with questions about the substance's regulation and safety. The GKC lobbying termination is one data point in an ongoing conversation about how industry groups navigate federal policy on botanical products.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article